
Keywords: CDXs; CTC-derived explants; CNV; copy number variation; CTCs; circulating tumor cells; CSCs; cancer stem cells; CtDNA; circulating tumor DNA; DCIS; ductal carcinoma in situ; ITH; intratumor heterogeneity; LCM; laser capture micro-dissection; NCCR; Nationa